115 related articles for article (PubMed ID: 19649002)
1. Renal stone disease in Christchurch, New Zealand. Part 2: a community study on the burden of renal stone disease.
Davidson PJ; Sheerin IG; Frampton C
N Z Med J; 2009 Jun; 122(1297):57-67. PubMed ID: 19649002
[TBL] [Abstract][Full Text] [Related]
2. Renal stone disease in Christchurch, New Zealand. Part 1: presentation and epidemiology.
Davidson PJ; Sheerin IG; Frampton C
N Z Med J; 2009 Jun; 122(1297):49-56. PubMed ID: 19649001
[TBL] [Abstract][Full Text] [Related]
3. Pediatric urinary stone disease--does age matter?
Kalorin CM; Zabinski A; Okpareke I; White M; Kogan BA
J Urol; 2009 May; 181(5):2267-71; discussion 2271. PubMed ID: 19296968
[TBL] [Abstract][Full Text] [Related]
4. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi.
Grasso M; Conlin M; Bagley D
J Urol; 1998 Aug; 160(2):346-51. PubMed ID: 9679874
[TBL] [Abstract][Full Text] [Related]
5. Economic cost of community-acquired pneumonia in New Zealand adults.
Scott G; Scott H; Turley M; Baker M
N Z Med J; 2004 Jun; 117(1196):U933. PubMed ID: 15280937
[TBL] [Abstract][Full Text] [Related]
6. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
7. A new transportable shock-wave lithotripsy machine for managing urinary stones: a single-centre experience with a dual-focus lithotripter.
De Sio M; Autorino R; Quarto G; Mordente S; Giugliano F; Di Giacomo F; Neri F; Quattrone C; Sorrentino D; De Domenico R; D'Armiento M
BJU Int; 2007 Nov; 100(5):1137-41. PubMed ID: 17550410
[TBL] [Abstract][Full Text] [Related]
8. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
9. Preoperative stent placement decreases cost of ureteroscopy.
Chu L; Farris CA; Corcoran AT; Averch TD
Urology; 2011 Aug; 78(2):309-13. PubMed ID: 21703670
[TBL] [Abstract][Full Text] [Related]
10. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective.
Nicholl D; Akhras KS; Diels J; Schadrack J
Curr Med Res Opin; 2010 Apr; 26(4):943-55. PubMed ID: 20163295
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of the Dornier Doli S lithotripter for renal stones.
Hoag CC; Taylor WN; Rowley VA
Can J Urol; 2006 Dec; 13(6):3358-63. PubMed ID: 17187703
[TBL] [Abstract][Full Text] [Related]
12. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of treating ureteral stones in a Taipei City Hospital: shock wave lithotripsy versus ureteroscopy plus lithoclast.
Huang CY; Chen SS; Chen LK
Urol Int; 2009; 83(4):410-5. PubMed ID: 19996647
[TBL] [Abstract][Full Text] [Related]
14. Charlson comorbidity index and success of extracorporeal shock wave lithotripsy.
Hubert KC; Singh M; Zhou EH; Delos Santos G; Stovsky MD
Can J Urol; 2009 Aug; 16(4):4733-5. PubMed ID: 19671224
[TBL] [Abstract][Full Text] [Related]
15. Ureteral stone location at emergency room presentation with colic.
Eisner BH; Reese A; Sheth S; Stoller ML
J Urol; 2009 Jul; 182(1):165-8. PubMed ID: 19450856
[TBL] [Abstract][Full Text] [Related]
16. Ureteric stents compromise stone clearance after shockwave lithotripsy for ureteric stones: results of a matched-pair analysis.
Argyropoulos AN; Tolley DA
BJU Int; 2009 Jan; 103(1):76-80. PubMed ID: 18710453
[TBL] [Abstract][Full Text] [Related]
17. The cost of multiple sclerosis in Australia.
Taylor B; McDonald E; Fantino B; Sedal L; MacDonnell R; Pittas F; Groom T; Beresniak A
J Clin Neurosci; 2007 Jun; 14(6):532-9. PubMed ID: 17430777
[TBL] [Abstract][Full Text] [Related]
18. The cost of campylobacteriosis in New Zealand in 1995.
Withington SG; Chambers ST
N Z Med J; 1997 Jun; 110(1046):222-4. PubMed ID: 9236803
[TBL] [Abstract][Full Text] [Related]
19. Outcomes using a fourth-generation lithotripter: a new benchmark for comparison?
Nomikos MS; Sowter SJ; Tolley DA
BJU Int; 2007 Dec; 100(6):1356-60. PubMed ID: 17850387
[TBL] [Abstract][Full Text] [Related]
20. Morbidity, mortality and economic burden of renal impairment in cardiac intensive care.
Chew DP; Astley C; Molloy D; Vaile J; De Pasquale CG; Aylward P
Intern Med J; 2006 Mar; 36(3):185-92. PubMed ID: 16503954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
